Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

CME vs NDAQ vs ICE vs CBOE

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CME
CME Group Inc.

Financial - Data & Stock Exchanges

Financial ServicesNASDAQ • US
Market Cap$104.61B
5Y Perf.+57.9%
NDAQ
Nasdaq, Inc.

Financial - Data & Stock Exchanges

Financial ServicesNASDAQ • US
Market Cap$50.71B
5Y Perf.+125.9%
ICE
Intercontinental Exchange, Inc.

Financial - Data & Stock Exchanges

Financial ServicesNYSE • US
Market Cap$86.89B
5Y Perf.+57.7%
CBOE
Cboe Global Markets, Inc.

Financial - Data & Stock Exchanges

Financial ServicesAMEX • US
Market Cap$36.08B
5Y Perf.+223.5%

CME vs NDAQ vs ICE vs CBOE — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CME logoCME
NDAQ logoNDAQ
ICE logoICE
CBOE logoCBOE
IndustryFinancial - Data & Stock ExchangesFinancial - Data & Stock ExchangesFinancial - Data & Stock ExchangesFinancial - Data & Stock Exchanges
Market Cap$104.61B$50.71B$86.89B$36.08B
Revenue (TTM)$6.52B$8.22B$12.64B$4.71B
Net Income (TTM)$4.24B$1.91B$3.30B$1.10B
Gross Margin86.1%47.9%61.9%48.9%
Operating Margin64.9%28.4%38.7%32.1%
Forward P/E23.6x22.7x19.1x27.5x
Total Debt$3.76B$9.93B$20.28B$1.68B
Cash & Equiv.$4.42B$814M$837M$2.22B

CME vs NDAQ vs ICE vs CBOELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CME
NDAQ
ICE
CBOE
StockMay 20May 26Return
CME Group Inc. (CME)100157.9+57.9%
Nasdaq, Inc. (NDAQ)100225.9+125.9%
Intercontinental Ex… (ICE)100157.7+57.7%
Cboe Global Markets… (CBOE)100323.5+223.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: CME vs NDAQ vs ICE vs CBOE

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CBOE leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Intercontinental Exchange, Inc. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. CME also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
CME
CME Group Inc.
The Banking Pick

CME is the clearest fit if your priority is dividends.

  • 3.8% yield, 6-year raise streak, vs ICE's 1.3%
Best for: dividends
NDAQ
Nasdaq, Inc.
The Financial Play

NDAQ lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: financial services exposure
ICE
Intercontinental Exchange, Inc.
The Banking Pick

ICE is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.

  • Dividend streak 14 yrs, beta 0.33, yield 1.3%
  • Lower volatility, beta 0.33, Low D/E 69.9%, current ratio 1.02x
  • Beta 0.33, yield 1.3%, current ratio 1.02x
  • Lower P/E (19.1x vs 22.7x)
Best for: income & stability and sleep-well-at-night
CBOE
Cboe Global Markets, Inc.
The Banking Pick

CBOE carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 15.1%, EPS growth 44.5%
  • 473.5% 10Y total return vs NDAQ's 351.9%
  • PEG 1.41 vs ICE's 2.15
  • 15.1% NII/revenue growth vs CME's 6.4%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthCBOE logoCBOE15.1% NII/revenue growth vs CME's 6.4%
ValueICE logoICELower P/E (19.1x vs 22.7x)
Quality / MarginsCBOE logoCBOEEfficiency ratio 0.2% vs ICE's 0.2% (lower = leaner)
Stability / SafetyICE logoICEBeta 0.33 vs NDAQ's 0.78, lower leverage
DividendsCME logoCME3.8% yield, 6-year raise streak, vs ICE's 1.3%
Momentum (1Y)CBOE logoCBOE+48.8% vs ICE's -11.3%
Efficiency (ROA)CBOE logoCBOEEfficiency ratio 0.2% vs ICE's 0.2%

CME vs NDAQ vs ICE vs CBOE — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CMECME Group Inc.
FY 2025
clearing and transaction fees
81.0%$5.3B
MarketData
12.3%$803M
OtherRevenue
6.7%$436M
NDAQNasdaq, Inc.
FY 2025
Market Services
51.4%$4.2B
Capital Access Platforms
26.1%$2.1B
Market Technology
22.6%$1.9B
ICEIntercontinental Exchange, Inc.
FY 2025
Fixed Income And Data Services Segment
51.1%$1.4B
Exchanges Segment
38.8%$1.0B
Mortgage Technology Segment
10.1%$269M
CBOECboe Global Markets, Inc.
FY 2025
Transaction And Clearing Fees
76.3%$3.6B
Access And Capacity Fees
8.7%$409M
Market Data Fees
6.9%$327M
Regulatory Fees
6.1%$285M
Other Revenue
2.0%$96M

CME vs NDAQ vs ICE vs CBOE — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCBOELAGGINGNDAQ

Income & Cash Flow (Last 12 Months)

CME leads this category, winning 4 of 5 comparable metrics.

ICE is the larger business by revenue, generating $12.6B annually — 2.7x CBOE's $4.7B. CME is the more profitable business, keeping 62.0% of every revenue dollar as net income compared to NDAQ's 21.8%.

MetricCME logoCMECME Group Inc.NDAQ logoNDAQNasdaq, Inc.ICE logoICEIntercontinental …CBOE logoCBOECboe Global Marke…
RevenueTrailing 12 months$6.5B$8.2B$12.6B$4.7B
EBITDAEarnings before interest/tax$4.7B$3.1B$6.5B$1.6B
Net IncomeAfter-tax profit$4.2B$1.9B$3.3B$1.1B
Free Cash FlowCash after capex$4.4B$2.0B$4.3B$1.2B
Gross MarginGross profit ÷ Revenue+86.1%+47.9%+61.9%+48.9%
Operating MarginEBIT ÷ Revenue+64.9%+28.4%+38.7%+32.1%
Net MarginNet income ÷ Revenue+62.0%+21.8%+26.1%+23.3%
FCF MarginFCF ÷ Revenue+64.3%+24.2%+33.9%+24.5%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year+21.4%+33.8%+23.1%+59.7%
CME leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

ICE leads this category, winning 4 of 7 comparable metrics.

At 25.8x trailing earnings, CME trades at a 22% valuation discount to CBOE's 33.1x P/E. Adjusting for growth (PEG ratio), CBOE offers better value at 1.69x vs ICE's 2.99x — a lower PEG means you pay less per unit of expected earnings growth.

MetricCME logoCMECME Group Inc.NDAQ logoNDAQNasdaq, Inc.ICE logoICEIntercontinental …CBOE logoCBOECboe Global Marke…
Market CapShares × price$104.6B$50.7B$86.9B$36.1B
Enterprise ValueMkt cap + debt − cash$103.9B$59.8B$106.3B$35.5B
Trailing P/EPrice ÷ TTM EPS25.84x28.87x26.59x33.05x
Forward P/EPrice ÷ next-FY EPS est.23.61x22.70x19.14x27.46x
PEG RatioP/E ÷ EPS growth rate1.88x2.70x2.99x1.69x
EV / EBITDAEnterprise value multiple23.08x20.18x16.47x21.72x
Price / SalesMarket cap ÷ Revenue16.04x6.17x6.88x7.65x
Price / BookPrice ÷ Book value/share3.62x4.20x3.02x7.05x
Price / FCFMarket cap ÷ FCF24.95x25.49x20.26x31.29x
ICE leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

CBOE leads this category, winning 5 of 9 comparable metrics.

CBOE delivers a 23.0% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $12 for ICE. CME carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to NDAQ's 0.81x. On the Piotroski fundamental quality scale (0–9), NDAQ scores 9/9 vs CME's 5/9, reflecting strong financial health.

MetricCME logoCMECME Group Inc.NDAQ logoNDAQNasdaq, Inc.ICE logoICEIntercontinental …CBOE logoCBOECboe Global Marke…
ROE (TTM)Return on equity+15.3%+15.9%+11.6%+23.0%
ROA (TTM)Return on assets+2.2%+6.4%+2.3%+12.2%
ROICReturn on invested capital+10.2%+8.1%+7.5%+17.9%
ROCEReturn on capital employed+3.6%+10.2%+9.5%+22.7%
Piotroski ScoreFundamental quality 0–95997
Debt / EquityFinancial leverage0.13x0.81x0.70x0.33x
Net DebtTotal debt minus cash-$666M$9.1B$19.4B-$532M
Cash & Equiv.Liquid assets$4.4B$814M$837M$2.2B
Total DebtShort + long-term debt$3.8B$9.9B$20.3B$1.7B
Interest CoverageEBIT ÷ Interest expense41.55x14.11x6.53x40.58x
CBOE leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CBOE leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in CBOE five years ago would be worth $33,164 today (with dividends reinvested), compared to $14,243 for ICE. Over the past 12 months, CBOE leads with a +48.8% total return vs ICE's -11.3%. The 3-year compound annual growth rate (CAGR) favors CBOE at 37.1% vs ICE's 14.0% — a key indicator of consistent wealth creation.

MetricCME logoCMECME Group Inc.NDAQ logoNDAQNasdaq, Inc.ICE logoICEIntercontinental …CBOE logoCBOECboe Global Marke…
YTD ReturnYear-to-date+9.7%-7.4%-3.8%+39.1%
1-Year ReturnPast 12 months+5.9%+15.6%-11.3%+48.8%
3-Year ReturnCumulative with dividends+72.2%+67.7%+48.2%+157.8%
5-Year ReturnCumulative with dividends+64.1%+71.7%+42.4%+231.6%
10-Year ReturnCumulative with dividends+291.2%+351.9%+222.9%+473.5%
CAGR (3Y)Annualised 3-year return+19.9%+18.8%+14.0%+37.1%
CBOE leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CME and CBOE each lead in 1 of 2 comparable metrics.

CME is the less volatile stock with a -0.30 beta — it tends to amplify market swings less than NDAQ's 0.78 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBOE currently trades 99.4% from its 52-week high vs ICE's 81.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCME logoCMECME Group Inc.NDAQ logoNDAQNasdaq, Inc.ICE logoICEIntercontinental …CBOE logoCBOECboe Global Marke…
Beta (5Y)Sensitivity to S&P 500-0.30x0.78x0.33x-0.27x
52-Week HighHighest price in past year$329.16$101.79$189.35$346.48
52-Week LowLowest price in past year$257.17$77.09$143.17$212.75
% of 52W HighCurrent price vs 52-week peak+87.6%+87.6%+81.0%+99.4%
RSI (14)Momentum oscillator 0–10041.752.042.075.1
Avg Volume (50D)Average daily shares traded2.2M3.3M3.1M876K
Evenly matched — CME and CBOE each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — CME and ICE each lead in 1 of 2 comparable metrics.

Analyst consensus: CME as "Hold", NDAQ as "Buy", ICE as "Buy", CBOE as "Hold". Consensus price targets imply 28.5% upside for NDAQ (target: $115) vs -14.1% for CBOE (target: $296). For income investors, CME offers the higher dividend yield at 3.79% vs CBOE's 0.79%.

MetricCME logoCMECME Group Inc.NDAQ logoNDAQNasdaq, Inc.ICE logoICEIntercontinental …CBOE logoCBOECboe Global Marke…
Analyst RatingConsensus buy/hold/sellHoldBuyBuyHold
Price TargetConsensus 12-month target$320.25$114.60$195.71$296.00
# AnalystsCovering analysts35363631
Dividend YieldAnnual dividend ÷ price+3.8%+1.2%+1.3%+0.8%
Dividend StreakConsecutive years of raises6131410
Dividend / ShareAnnual DPS$10.92$1.04$1.93$2.71
Buyback YieldShare repurchases ÷ mkt cap+0.3%+1.2%+1.6%+0.3%
Evenly matched — CME and ICE each lead in 1 of 2 comparable metrics.
Key Takeaway

CBOE leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). CME leads in 1 (Income & Cash Flow). 2 tied.

Best OverallCboe Global Markets, Inc. (CBOE)Leads 2 of 6 categories
Loading custom metrics...

CME vs NDAQ vs ICE vs CBOE: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is CME or NDAQ or ICE or CBOE a better buy right now?

For growth investors, Cboe Global Markets, Inc.

(CBOE) is the stronger pick with 15. 1% revenue growth year-over-year, versus 6. 4% for CME Group Inc. (CME). CME Group Inc. (CME) offers the better valuation at 25. 8x trailing P/E (23. 6x forward), making it the more compelling value choice. Analysts rate Nasdaq, Inc. (NDAQ) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CME or NDAQ or ICE or CBOE?

On trailing P/E, CME Group Inc.

(CME) is the cheapest at 25. 8x versus Cboe Global Markets, Inc. at 33. 1x. On forward P/E, Intercontinental Exchange, Inc. is actually cheaper at 19. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Cboe Global Markets, Inc. wins at 1. 41x versus Intercontinental Exchange, Inc. 's 2. 15x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — CME or NDAQ or ICE or CBOE?

Over the past 5 years, Cboe Global Markets, Inc.

(CBOE) delivered a total return of +231. 6%, compared to +42. 4% for Intercontinental Exchange, Inc. (ICE). Over 10 years, the gap is even starker: CBOE returned +473. 5% versus ICE's +222. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CME or NDAQ or ICE or CBOE?

By beta (market sensitivity over 5 years), CME Group Inc.

(CME) is the lower-risk stock at -0. 30β versus Nasdaq, Inc. 's 0. 78β — meaning NDAQ is approximately -358% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 81% for Nasdaq, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — CME or NDAQ or ICE or CBOE?

By revenue growth (latest reported year), Cboe Global Markets, Inc.

(CBOE) is pulling ahead at 15. 1% versus 6. 4% for CME Group Inc. (CME). On earnings-per-share growth, the picture is similar: Nasdaq, Inc. grew EPS 60. 1% year-over-year, compared to 15. 4% for CME Group Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CME or NDAQ or ICE or CBOE?

CME Group Inc.

(CME) is the more profitable company, earning 62. 0% net margin versus 21. 8% for Nasdaq, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 28. 4% for NDAQ. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CME or NDAQ or ICE or CBOE more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Cboe Global Markets, Inc. (CBOE) is the more undervalued stock at a PEG of 1. 41x versus Intercontinental Exchange, Inc. 's 2. 15x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Intercontinental Exchange, Inc. (ICE) trades at 19. 1x forward P/E versus 27. 5x for Cboe Global Markets, Inc. — 8. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NDAQ: 28. 5% to $114. 60.

08

Which pays a better dividend — CME or NDAQ or ICE or CBOE?

All stocks in this comparison pay dividends.

CME Group Inc. (CME) offers the highest yield at 3. 8%, versus 0. 8% for Cboe Global Markets, Inc. (CBOE).

09

Is CME or NDAQ or ICE or CBOE better for a retirement portfolio?

For long-horizon retirement investors, Cboe Global Markets, Inc.

(CBOE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 27), 0. 8% yield, +473. 5% 10Y return). Both have compounded well over 10 years (CBOE: +473. 5%, NDAQ: +351. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CME and NDAQ and ICE and CBOE?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CME is a mid-cap income-oriented stock; NDAQ is a mid-cap quality compounder stock; ICE is a mid-cap quality compounder stock; CBOE is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

CME

Dividend Mega-Cap Quality

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 37%
Run This Screen
Stocks Like

NDAQ

Quality Mega-Cap Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 13%
Run This Screen
Stocks Like

ICE

Quality Mega-Cap Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 15%
Run This Screen
Stocks Like

CBOE

High-Growth Quality Leader

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 14%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CME and NDAQ and ICE and CBOE on the metrics below

Revenue Growth>
%
(CME: 6.4% · NDAQ: 11.1%)
Net Margin>
%
(CME: 62.0% · NDAQ: 21.8%)
P/E Ratio<
x
(CME: 25.8x · NDAQ: 28.9x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.